Dermavant Unveils VTAMA Cream Data for Atopic Dermatitis
Dermavant Sciences has released promising data from their ADORING 3 study, highlighting the effectiveness of VTAMA cream, 1% in...
Engene Secures $60 Million in Private Placement Financing
enGene Holdings Inc., a clinical-stage genetic medicines company, has entered into an agreement to sell 6,758,311 of its common...
Odyssey Therapeutics Presents New Data on RIPK2 Inhibitor at ACG 2024
Odyssey Therapeutics, a clinical-stage biopharmaceutical company, is set to present promising data on its receptor-interacting protein kinase 2 (RIPK2)...
ABIONYX Presents Positive RACERS Study Results at ASN Kidney Week 2024
ABIONYX Pharma, a company focused on developing innovative therapies using recombinant human apoA-I, announced that its Phase 2b RACERS...
Precision Biosciences Announces First-in-Human Study for Chronic Hepatitis B Treatment
Precision BioSciences, a clinical-stage gene editing company, has announced a significant advancement in its quest to cure chronic hepatitis...
Predicting First-Line Incontinence Treatment Success in Women
Researchers have developed a potential machine learning model that could personalize treatments for female pelvic floor disorders, specifically urinary...
Prevnar 20® Recommended for Adults 50+ by ACIP
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practice (ACIP) has recommended expanding the...
Nanoknife® System’s Long-Term Effects Studied in New Trial
AngioDynamics, a medical technology company specializing in vascular health and cancer treatment, has initiated a global registry study to...
OPM-101 RIPK2 Inhibitor Shows Strong Safety, No Cardiac Toxicity in Phase 1 Study
Oncodesign Precision Medicine (OPM) has announced the successful completion of its Phase 1 clinical trial for OPM-101, an orally...
Medable: Top Patient Engagement Trailblazer by Everest Group
Medable, a leading clinical trial technology platform, has been recognized as a Trailblazer in Everest Group’s first-ever “Clinical Trial...